Herein, we aimed to validate the SCAN-B multicenter infrastructure and provide molecular analyses of clinical value by developing RNA-seq–derived classifiers for the conventional histopathologic BC biomarkers ER, PgR, HER2, Ki67, and NHG. Here, ERBB2 is linked to breast cancer.